We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Single Amino Acid Controls Signaling Molecule Activity

By LabMedica International staff writers
Posted on 09 Jan 2018
Print article
Image: Probes revealed the inner architecture when the A2AAR protein transmitted molecular signals through a cell membrane (Photo courtesy of Drs. Kurt Wüthrich and Matthew Eddy, The Scripps Research Institute).
Image: Probes revealed the inner architecture when the A2AAR protein transmitted molecular signals through a cell membrane (Photo courtesy of Drs. Kurt Wüthrich and Matthew Eddy, The Scripps Research Institute).
An advanced NMR (nuclear magnetic resonance) spectroscopy technique was used to follow the dynamic structural changes that occurred during binding of a drug to a cell membrane-spanning G protein-coupled receptor.

The 826 human G protein-coupled receptors (GPCRs), which are involved in signaling across cellular membranes, govern a wide range of vital physiological processes, making GPCRs prominent drug targets.

X-ray crystallography techniques have provided GPCR molecular architectures, but these methods lack the ability to detail additional structural dynamics that occur when the molecules are in motion. To complete this picture, investigators at The Scripps Research Institute (La Jolla, CA, USA) used NMR spectroscopy to study the wild-type-like A2A adenosine receptor (A2AAR) in solution. A2AAR is a GPCR that regulates blood flow and inflammation and mediates the effects of caffeine. A2AAR is a validated target for treating Parkinson's disease and a relatively new target for targeting cancers.

To carry out this study the investigators assigned individual chemical markers to each of six tryptophan indole and eight glycine backbone NMR signals in A2AAR. These NMR probes provided insight into the role of a specific aspartic acid (Asp) moiety as an allosteric link between the drug binding site and the intracellular signaling surface.

Results published in the December 2, 2017, online edition of the journal Cell revealed that modifying or replacing this particular amino acid in the center of the receptor destroyed the receptor's ability to send signals into the cell. Furthermore, the NMR data showed that one of the tryptophan amino acids in A2AAR acted as a "toggle switch" by flipping up and down in concert with A2AAR's activity.

"This basic knowledge is potentially helpful for improving drug design," said senior author, the Nobel Prize winning Dr. Kurt Wüthrich, professor of structural biology at The Scripps Research Institute. "GPCRs do just about everything you can imagine, but for a long time, drug design was being done without knowing how GPCRs looked. With this finding, we can say "A-ha! It is this change in structure that kills the signaling activity." Maybe we can make a change in a drug to overcome this limit."

Related Links:
The Scripps Research Institute

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.